Antitumor activity of nifurtimox observed in a patient with neuroblastoma.


BACKGROUND Chemotherapy-resistant neuroblastoma is a difficult disease to treat with poor survival. OBSERVATIONS We treated a patient with neuroblastoma who had progressed on conventional chemotherapy. This 5-year-old girl with chemotherapy-resistant neuroblastoma developed Chagas disease at the start of salvage chemotherapy for which she was also started on nifurtimox. The neuroblastoma response to these treatments resulted in clinical remission. In vitro, treatment of a neuroblastoma cell line with nifurtimox resulted in decreased cell viability whereas no effect was seen on an endothelial cell line. CONCLUSIONS Nifurtimox shows promise as a potential new treatment for neuroblastoma and warrants further testing.


Citations per Year

70 Citations

Semantic Scholar estimates that this publication has 70 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Sholler2006AntitumorAO, title={Antitumor activity of nifurtimox observed in a patient with neuroblastoma.}, author={Giselle Saulnier Sholler and Satyan S. Kalkunte and Carla Greenlaw and Kathleen M. McCarten and Edwin Forman}, journal={Journal of pediatric hematology/oncology}, year={2006}, volume={28 10}, pages={693-5} }